메뉴 건너뛰기




Volumn 28, Issue 42067, 1998, Pages 371-375

Ceca–Cyclophosphamide, Etoposide, Carboplatin and Cytosine Arabinoside–A New Salvage Regimen for Relapsed or Refractory Acute Myelogenous Leukemia

Author keywords

Acute myelogenous leukemia; salvage therapy

Indexed keywords

ANTILEUKEMIC AGENT; BILIRUBIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE;

EID: 0031881152     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199809092692     Document Type: Article
Times cited : (8)

References (18)
  • 1
    • 0027534992 scopus 로고
    • The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen-year period
    • Davis C., Rohatiner A., Lim J., Whelan J., Oza A., Amess J., Love S., Stead E., Lister T. The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen-year period. Br J Haematol 1993; 83: 404 – 11
    • (1993) Br J Haematol , vol.83 , pp. 404-411
    • Davis, C.1    Rohatiner, A.2    Lim, J.3    Whelan, J.4    Oza, A.5    Amess, J.6    Love, S.7    Stead, E.8    Lister, T.9
  • 3
    • 0025273524 scopus 로고
    • Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: A proposal based on the results of retreatment by Thioguanine, cytosine Arabinoside, and Daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapy
    • Hiddemann W., Martin W., Sauerland C., Heinecke A., Buchner T. Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: A proposal based on the results of retreatment by Thioguanine, cytosine Arabinoside, and Daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapy. Leukemia 1990; 4: 184 – 8
    • (1990) Leukemia , vol.4 , pp. 184-188
    • Hiddemann, W.1    Martin, W.2    Sauerland, C.3    Heinecke, A.4    Buchner, T.5
  • 4
    • 0023028589 scopus 로고
    • Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial
    • Rees J., Swirsky D., Gray R., Hayhoe F. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial. Lancet 1986; 1236 – 41
    • (1986) Lancet , pp. 1236-1241
    • Rees, J.1    Swirsky, D.2    Gray, R.3    Hayhoe, F.4
  • 5
    • 0023816181 scopus 로고
    • Impact of rein-duction regimens on the clinical course of adult acute nonlymphocytic leukemia
    • Welborn J., Lewis J., Meyers F. Impact of rein-duction regimens on the clinical course of adult acute nonlymphocytic leukemia. Leukemia 1988; 2: 711 – 6
    • (1988) Leukemia , vol.2 , pp. 711-716
    • Welborn, J.1    Lewis, J.2    Meyers, F.3
  • 7
    • 0028077347 scopus 로고
    • A phase III trial of high-dose cytarabine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia a Southeastern Cancer Study Group trial
    • Vogler W. R., McCarley D. L., Stagg M., Bartolucci A. A., Moore J., Martelo O., Omura G. A. A phase III trial of high-dose cytarabine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia a Southeastern Cancer Study Group trial. Leukemia 1994; 8 (11) 1847 – 53
    • (1994) Leukemia , vol.8 , Issue.11 , pp. 1847-1853
    • Vogler, W.R.1    McCarley, D.L.2    Stagg, M.3    Bartolucci, A.A.4    Moore, J.5    Martelo, O.6    Omura, G.A.7
  • 8
    • 0029943332 scopus 로고    scopus 로고
    • A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia
    • Estey E., Kornblau S., Pierce S., Kantarjian H., Beran M., Keating M. A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia. Blood 1996; 88 (2) 756
    • (1996) Blood , vol.88 , Issue.2 , pp. 756
    • Estey, E.1    Kornblau, S.2    Pierce, S.3    Kantarjian, H.4    Beran, M.5    Keating, M.6
  • 11
    • 0013244016 scopus 로고
    • A phase II trial of VP-16–213 in adults with refractory acute myelogenous leukemia
    • Bennet J., Lymann G., Cassilith P., Glick J., Oken M. A phase II trial of VP-16–213 in adults with refractory acute myelogenous leukemia. Am J Clin Path 1984; 7: 471 – 3
    • (1984) Am J Clin Path , vol.7 , pp. 471-473
    • Bennet, J.1    Lymann, G.2    Cassilith, P.3    Glick, J.4    Oken, M.5
  • 12
    • 0020453093 scopus 로고
    • Etoposide in the treatment of acute leukemia in adults
    • Varini M., Cavilli F. Etoposide in the treatment of acute leukemia in adults. Cancer Treat Rev 1982; 9: 59 – 62
    • (1982) Cancer Treat Rev , vol.9 , pp. 59-62
    • Varini, M.1    Cavilli, F.2
  • 13
    • 0028122277 scopus 로고
    • Carboplatin and etoposide in acute myeloid leukemia
    • Sanz M. A., Bonanad S., Sanz G. F., Martin G. Carboplatin and etoposide in acute myeloid leukemia. Leukemia 1994; 8: 1599 – 600
    • (1994) Leukemia , vol.8 , pp. 1599-1600
    • Sanz, M.A.1    Bonanad, S.2    Sanz, G.F.3    Martin, G.4
  • 14
    • 6844256087 scopus 로고
    • A phase II clinical trial of carboplatin in relapsed and refractory leukemia by the Eastern Cooperative Oncology Group. [Abstract]
    • Vogler W., Lazarus H., Winton E., et al. A phase II clinical trial of carboplatin in relapsed and refractory leukemia by the Eastern Cooperative Oncology Group. [Abstract]. Blood 1990; 76 (Supplement 1) 332
    • (1990) Blood , vol.76 , pp. 332
    • Vogler, W.1    Lazarus, H.2    Winton, E.3
  • 16
    • 0023713591 scopus 로고
    • Phase I and pharmacokinetic trial of carboplatin in refractory adult leukemia
    • Lee E., Egorin M., Van Echo D., Cohen A., Tait N., Schiffler C. A. Phase I and pharmacokinetic trial of carboplatin in refractory adult leukemia. JNCI 1988; 80: 131 – 5
    • (1988) JNCI , vol.80 , pp. 131-135
    • Lee, E.1    Egorin, M.2    Van Echo, D.3    Cohen, A.4    Tait, N.5    Schiffler, C.A.6
  • 17
    • 6844261377 scopus 로고    scopus 로고
    • Recruitment of topoisomerase I following DNA damage in human cells
    • Muller M., Rosenstein B., Subramaman D. Recruitment of topoisomerase I following DNA damage in human cells. Proc AACR 1996; 37: 637
    • (1996) Proc AACR , vol.37 , pp. 637
    • Muller, M.1    Rosenstein, B.2    Subramaman, D.3
  • 18
    • 0027425758 scopus 로고
    • A phase I trial of carboplatin and etoposide given as continuous infusion to adults with leukemia
    • Lee E., Reck K., Carter C., Hodges S., Schiffer C. A. A phase I trial of carboplatin and etoposide given as continuous infusion to adults with leukemia. Leukemia 1993; 7 (10) 1500 – 3
    • (1993) Leukemia , vol.7 , Issue.10 , pp. 1500-1503
    • Lee, E.1    Reck, K.2    Carter, C.3    Hodges, S.4    Schiffer, C.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.